Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancer Transformative moment ...

Protein sequencing advance offers new insights into life's foundations

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...
Frontiers

Integrative Multi-Omics and Bioinformatics Approaches in Cardiovascular Disease

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, driven by complex and heterogeneous molecular mechanisms ...
Technology Networks

Clinical Multi-Omics Approaches for Systems Medicine and Biomarker Discovery

Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...
Frontiers

Editorial: Advancements in sequencing technologies for epigenomic and transcriptomic analysis: from bulk to single-cell resolution

Over the past decade, NGS technology has transformed the way to study and explore genomics, epigenomics, and transcriptomics. Improvements in throughput, and accuracy now allow researchers to move ...
The Patriot Ledger

OmicInsight and Psomagen Announce Strategic Marketing Agreement to Expand High-Resolution Spatial Transcriptomics

SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ — OmicInsight Corporation, an innovator in AI-powered spatial biology and high-resolution ...